As discussed elsewhere [1,2], we have argued that increases in the levels of SOX2 can contribute to tumor growth, provided the increases in SOX2 are accompanied by changes in the expression of other genes that are able to counter the growth inhibitory effects of increased SOX2. The gene discussed is SOX2; the disease is neoplasm.